STERIS plc - Asset Resilience Ratio
STERIS plc (STE) has an Asset Resilience Ratio of 4.00% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See STERIS plc (STE) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how STERIS plc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see STERIS plc assets under control.
Liquid Assets Composition Over Time
This chart breaks down STERIS plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read STE total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $423.70 Million | 4.0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $423.70 Million | 4.00% |
Asset Resilience Insights
- Limited Liquidity: STERIS plc maintains only 4.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
STERIS plc Industry Peers by Asset Resilience Ratio
Compare STERIS plc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for STERIS plc (2016–2025)
The table below shows the annual Asset Resilience Ratio data for STERIS plc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 1.69% | $171.70 Million | $10.15 Billion | -0.18pp |
| 2024-03-31 | 1.87% | $207.02 Million | $11.06 Billion | -0.05pp |
| 2023-03-31 | 1.93% | $208.36 Million | $10.82 Billion | -1.12pp |
| 2022-03-31 | 3.05% | $348.32 Million | $11.42 Billion | -0.31pp |
| 2021-03-31 | 3.35% | $220.53 Million | $6.57 Billion | -2.54pp |
| 2020-03-31 | 5.89% | $319.58 Million | $5.43 Billion | +1.54pp |
| 2019-03-31 | 4.35% | $220.63 Million | $5.07 Billion | +0.47pp |
| 2018-03-31 | 3.88% | $201.53 Million | $5.20 Billion | -1.87pp |
| 2017-03-31 | 5.75% | $282.92 Million | $4.92 Billion | -- |
| 2016-03-31 | 0.00% | $0.00 | $5.35 Billion | -- |
About STERIS plc
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital … Read more